SIA
AMGN icon

Schear Investment Advisers’s Amgen AMGN Stock Holding History

Schear Investment Advisers’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.27M Buy
6,265
+35
+0.6% +$12K 0.76% 37
2026
Q1 		$2.19M Buy
6,230
+39
+0.6% +$13.9K 0.97% 36
2025
Q4 		$2.03M Buy
6,191
+509
+9% +$161K 0.87% 39
2025
Q3 		$1.6M Sell
5,682
-3
-0.1% -$870 0.71% 44
2025
Q2 		$1.59M Buy
5,685
+39
+0.7% +$11K 0.79% 42
2025
Q1 		$1.76M Buy
5,646
+173
+3% +$51.1K 1.01% 34
2024
Q4 		$1.43M Sell
5,473
-332
-6% -$98.5K 0.76% 38
2024
Q3 		$1.87M Buy
5,805
+442
+8% +$145K 1.16% 26
2024
Q2 		$1.68M Buy
5,363
+1,131
+27% +$332K 1.21% 25
2024
Q1 		$1.2M Buy
4,232
+100
+2% +$29.3K 0.97% 32
2023
Q4 		$1.19M Sell
4,132
-18
-0.4% -$4.9K 1.15% 28
2023
Q3 		$1.12M Sell
4,150
-257
-6% -$64.1K 1.2% 26
2023
Q2 		$978K Buy
4,407
+9
+0.2% +$2.09K 1.03% 34
2023
Q1 		$1.06M Buy
4,398
+629
+17% +$154K 1.27% 27
2022
Q4 		$990K Buy
+3,769
New +$1.01M 1.22% 27

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Schear Investment Advisers's AMGN Position: Q2 2026 in Review

Schear Investment Advisers increased its Amgen (AMGN) stake by 0.56% in Q2 2026, buying an estimated $12K and bringing the position to 6,265 shares worth $2.27M. The position accounts for 0.76% of the portfolio, ranked #37.

Schear Investment Advisers first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Schear Investment Advisers held 6,265 shares of Amgen worth $2.27M as of Q2 2026.
  • Schear Investment Advisers bought 35 Amgen shares in Q2 2026, an estimated $12K.
  • Amgen made up 0.76% of Schear Investment Advisers's portfolio in Q2 2026, its #37 holding.
  • Schear Investment Advisers first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Schear Investment Advisers's 13F filing for Q2 2026, filed 27 Jul 2026.